NCT04462562View on ClinicalTrials.gov

Quantitative US for Evaluation of Hepatic Steatosis in NAFLD

NACompletedINTERVENTIONAL

Enrollment

173

Participants

Timeline

Start Date

July 3, 2020

Primary Completion Date

June 29, 2021

Study Completion Date

June 29, 2021

Conditions

Fatty LiverFatty Liver, Nonalcoholic

Interventions

DIAGNOSTIC_TEST

Quantitative US (Samsung Medison, RS85A)

In each patients, measurements of tissue attenuation imagine (TAI), tissue scatter-distribution imaging (TSI) parameters, hepatorenal index (EzHRI) will be performed

Trial Locations (1)

Unknown

Seoul National University Hospital, Seoul

All Listed Sponsors

collaborator

Samsung Medison

INDUSTRY

lead

Seoul National University Hospital

OTHER

NCT04462562 - Quantitative US for Evaluation of Hepatic Steatosis in NAFLD | Biotech Hunter | Biotech Hunter